Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist

NCT03293225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2019-07-08

No results posted yet for this study

Summary

A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria

Conditions

  • Chronic Urticaria

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • Youngmin Ye, Dr · Ajou University

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-24
Primary Completion
2019-05-24
Completion
2019-05-24

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03293225 on ClinicalTrials.gov